What Is a DHT Blocker and How Does It Work for Women’s Hair Loss?

A DHT blocker lowers the androgen that can shrink hair follicles, but the evidence in women is thinner than the marketing implies.

Shedding is not proof of a hormone problem. Thyroid disease, iron deficiency, telogen effluvium, alopecia areata, and postpartum shedding all mimic pattern hair loss, and each gets a different treatment. Understanding what a DHT blocker is and how it works for women’s hair loss means separating two questions: how the drug lowers the hormone, and whether that hormone is driving the shedding in front of you.

How Do DHT Blockers Work On Hair Follicles?

DHT blockers reduce dihydrotestosterone, the androgen made when 5-alpha-reductase converts testosterone, and follicles genetically sensitive to DHT miniaturize under repeated exposure.

1. 5-alpha-reductase converts testosterone into DHT.
2. DHT binds androgen receptors inside susceptible follicles.
3. Repeated androgen exposure shortens the growth phase, and each cycle produces a thinner hair.
4. A DHT-blocking drug cuts how much DHT forms or interferes with its action, which may slow further miniaturization.

Finasteride blocks type II 5-alpha-reductase. Dutasteride blocks both type I and type II. Neither restores follicles that have already closed down, and the benefit usually fades once the drug stops.

DHT Blockers For Women’s Hair Loss: What The Evidence Supports

No DHT blocker carries FDA approval for hair loss in women. Finasteride’s approved indication is male pattern hair loss, and its label states plainly that the drug is not indicated for women, making every female prescription an off-label judgment a clinician must own.

The same label reports the trial most sellers skip: a 12-month study of 137 postmenopausal women, 67 on finasteride and 70 on placebo, found no demonstrated effectiveness.

Dutasteride appears in Mayo Clinic’s list of hair loss treatments, without an FDA indication for women. Spironolactone appears there too, working differently — an antiandrogen rather than an enzyme inhibitor — with monitoring for blood pressure, potassium, kidney function, menstruation, and pregnancy.

Minoxidil remains the better-established pick for women. Mayo Clinic lists topical minoxidil as an over-the-counter treatment sold as liquid, foam, and shampoo, applied once daily, with results that can take at least six months and need continued use to hold. Scalp irritation and stray facial or hand hair are the usual complaints, and minoxidil does not block DHT — it works on the follicle’s growth cycle instead.

When a working treatment ends, the follicle returns to its previous trajectory within months, which is why a six-month trial with a review date beats an open-ended experiment.

Pregnancy Risk And The Order To Do Things In

Pregnancy is the hard stop. Finasteride is contraindicated in women who are or may become pregnant, because DHT is required for normal development of male fetal external genitalia, and pregnant women should not handle crushed or broken tablets — exposed skin gets washed with soap and water.

Anyone with pregnancy potential, liver or kidney disease, a hormonal disorder, or a long medication list needs a clinician’s assessment before touching a prescription DHT blocker. For what sits on the shelf, this breakdown of tested DHT blocker supplements for women covers the products themselves.

Start with the diagnosis, not the bottle. A clinician can separate pattern hair loss from telogen effluvium, thyroid disease, iron deficiency, alopecia areata, and medication-related shedding, often with an exam and lab work alone.

1. Get pattern hair loss confirmed, and rule out the mimics.
2. Ask whether a DHT blocker fits your history, including pregnancy plans.
3. Set a trial length before you start — minoxidil needs at least six months — and don’t quit early.